Hansson et al. revealed the potential of CSF concentrations of Aβ1–42, total tau (t-tau), and tau phosphorylated at threonine 181 (p-tau) in predicting the progression from MCI to AD [104]. This evidence concerns the gene MAPT and Alzheimer disease.